Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma - Docwire News Doc Wire News, 16 Jul 2021 This article was originally published here Front Cell Dev Biol. 2021 Jun 29;9:690796.